The Home Environment and Re-hospitalization in COPD study (HEAR COPD)
The Home Environment and Re-hospitalization in COPD study (HEAR COPD)
批准号:
10414045
负责人:
Nirupama Putcha
金额:
$60.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-15 至 2024-05-31
关键词:
Accident and Emergency departmentAcuteAirAir PollutionAllergensAllergicAsthmaAutomobile DrivingBackBacterial InfectionsBaltimoreBiometryCause of DeathCharacteristicsChronic Obstructive Pulmonary DiseaseClinicalClinical ResearchCohort StudiesCollaborationsCollectionComplexCost of IllnessDataData AnalyticsDirect CostsDiseaseDustEmergency department visitEnvironmentEnvironmental HealthEpidemiologyExposure toFacilities and Administrative CostsFutureGoalsHealth ExpendituresHomeHome environmentHospitalizationHospitalsHypersensitivityImmunologyIndividualIndoor Air PollutionIndoor environmentInfrastructureLung diseasesMeasuresMentored Patient-Oriented Research Career Development AwardMethodsModificationMorbidity - disease rateNitrogen DioxideObservational StudyOutcomeOutpatientsParticulate MatterPatientsPopulationPrevalenceProductivityResearchResearch InfrastructureResearch PersonnelRiskRisk FactorsSocietiesTestingUltrafineUnited StatesVirus DiseasesVisitVulnerable PopulationsWorkadverse outcomebaseclinical phenotypecoarse particlescohortcostdata managementeconomic costenvironmental interventionenvironmental tobacco smokeexperiencefine particlesformer smokerhealth care service utilizationhigh riskhigh risk populationhospital readmissionimproved outcomeindexingindoor allergenindoor pollutantinterestlung healthmodifiable riskmultimodalitypollutantprimary outcomerecruitsocietal coststherapy designultrafine particle
中文摘要
点击翻译按钮获取中文摘要
英文摘要
COPD is a costly disease with a large burden of costs driven by healthcare utilization during acute exacerbations
of illness, particularly those driven by emergency room and hospital visits. Additionally, a large proportion of
individuals with COPD recently hospitalized for acute exacerbations are re-hospitalized both within one month
but also within a year. These re-hospitalizations place a tremendous burden of cost on society not just due to
direct costs but also indirect costs and lost productivity. A majority of individuals with COPD are discharged
home, back to the very environment that was likely contributing to their disease morbidity. Indoor air pollution
and allergen sensitization with exposure are important components of the home environment that likely
contribute to exacerbation risk as has been shown in mostly stable, outpatient populations of former smokers
with COPD. However, little is known about these factors in the highly vulnerable population of individuals recently
hospitalized with COPD exacerbations, who have different characteristics and competing risks than stable
outpatient populations. Accordingly, we propose a single center observational study of individuals with COPD,
to be recruited during hospitalization for COPD exacerbation. We hypothesize that in-home air pollution,
including ultrafine and fine particulate matter and nitrogen dioxide (Specific Aim 1) as well as allergen
sensitization with exposure (Specific Aim 2) will be associated with heightened risk for the primary outcome of
interest, re-hospitalization for COPD exacerbation. The home environment will be assessed within 1 week of
discharge from the hospital, and again at 3, 6, and 9 months post index hospitalization in addition to clinical
measures. Outcomes will be assessed up to one year post index hospitalization. This study will provide much
needed information about the contribution of indoor air pollution and allergen sensitization with exposure to re-
hospitalizations in the high-risk population of individuals with COPD recently hospitalized for exacerbation. We
believe that this study can provide valuable information which can ultimately be utilized to design interventions
to modify the home environment post-hospital discharge with the goal to improve outcomes including re-
hospitalization risk in COPD.
1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated Health Sciences Facility Core
-
批准号:10652261
-
项目类别:
-
资助金额:$19.87万
-
财政年份:2022
-
负责人:Nirupama Putcha
-
依托单位:
The Home Environment and Re-hospitalization in COPD study (HEAR COPD)
-
批准号:10331367
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2021
-
负责人:Nirupama Putcha
-
依托单位:
The Home Environment and Re-hospitalization in COPD study (HEAR COPD)
-
批准号:10630924
-
项目类别:
-
资助金额:$60.57万
-
财政年份:2019
-
负责人:Nirupama Putcha
-
依托单位:
The Home Environment and Re-hospitalization in COPD study (HEAR COPD)
-
批准号:10017972
-
项目类别:
-
资助金额:$63.89万
-
财政年份:2019
-
负责人:Nirupama Putcha
-
依托单位:
The association of allergic disease with clinical outcomes in COPD.
-
批准号:9566375
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2015
-
负责人:Nirupama Putcha
-
依托单位:
The association of allergic disease with clinical outcomes in COPD.
-
批准号:8967303
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2015
-
负责人:Nirupama Putcha
-
依托单位:
海外基金